American Journal of Kidney Diseases
Volume 52, Issue 6 , Pages 1084-1095 , December 2008

Effect of Hydrochlorothiazide on Urinary Calcium Excretion in Dent Disease: An Uncontrolled Trial

  • Anne Blanchard, MD, PhD

      Affiliations

    • Université Paris 5, Faculté de Médecine Paris Descartes, France
    • Assistance Publique-Hôpitaux de Paris, Hôpital Européen George Pompidou, France
    • Centre d'Investigations Cliniques 9201, France
    • Corresponding Author InformationAddress correspondence to Anne Blanchard, MD, PhD, Centre d'Investigation Cliniques, Hôpital Européen Georges Pompidou, 20-40 rue Leblanc, F-75015 Paris
    • ,
  • Rosa Vargas-Poussou, MD, PhD

      Affiliations

    • Université Paris 5, Faculté de Médecine Paris Descartes, France
    • Assistance Publique-Hôpitaux de Paris, Hôpital Européen George Pompidou, France
    • Département de Génétique, France
    • INSERM U772, Paris, France
    • ,
  • Severine Peyrard, MSc

      Affiliations

    • Assistance Publique-Hôpitaux de Paris, Hôpital Européen George Pompidou, France
    • Centre d'Investigations Cliniques 9201, France
    • ,
  • Agnes Mogenet, MD

      Affiliations

    • Assistance Publique-Hôpitaux de Paris, Hôpital Necker Enfant Malade, France
    • Centre d'Investigations Cliniques, France
    • ,
  • Veronique Baudouin, MD, PhD

      Affiliations

    • Service de Néphrologie, France
    • Faculté de Médecine, Université Paris 7, France
    • Assistance Publique-Hôpitaux de Paris, Hôpital Robert Debré, France
    • ,
  • Bernard Boudailliez, MD, MSc

      Affiliations

    • Université de Picardie, faculté de médecine, Assistance Publique-Hôpitaux de Paris, France
    • Centre Hospitalier Amiens Sud, Département de Néphrologie Pédiatrique, France
    • ,
  • Marina Charbit, MD

      Affiliations

    • Université Paris 5, Faculté de Médecine Paris Descartes, France
    • Assistance Publique-Hôpitaux de Paris, Hôpital Necker Enfant Malade, France
    • Service de Néphrologie, France
    • ,
  • George Deschesnes, MD, PhD

      Affiliations

    • Service de Néphrologie, France
    • Faculté de Médecine, Université Paris 7, France
    • Assistance Publique-Hôpitaux de Paris, Hôpital Robert Debré, France
    • ,
  • Nadia Ezzhair, MD

      Affiliations

    • Assistance Publique-Hôpitaux de Paris, Hôpital Robert Debré, France
    • ,
  • Chantal Loirat, MD, PhD

      Affiliations

    • Service de Néphrologie, France
    • Faculté de Médecine, Université Paris 7, France
    • Assistance Publique-Hôpitaux de Paris, Hôpital Robert Debré, France
    • ,
  • Marie-Alice Macher, MD, PhD

      Affiliations

    • Service de Néphrologie, France
    • Faculté de Médecine, Université Paris 7, France
    • Assistance Publique-Hôpitaux de Paris, Hôpital Robert Debré, France
    • ,
  • Patrick Niaudet, MD, PhD

      Affiliations

    • Université Paris 5, Faculté de Médecine Paris Descartes, France
    • Assistance Publique-Hôpitaux de Paris, Hôpital Necker Enfant Malade, France
    • Faculté de Médecine, Université Paris 7, France
    • ,
  • Michel Azizi, MD, PhD

      Affiliations

    • Université Paris 5, Faculté de Médecine Paris Descartes, France
    • Assistance Publique-Hôpitaux de Paris, Hôpital Européen George Pompidou, France
    • Centre d'Investigations Cliniques 9201, France

Received 26 March 2008 ,Accepted 1 August 2008.

References 

  1. Igarashi T, Gunther W, Sekine T, et al. Functional characterization of renal chloride channel, CLCN5, mutations associated with Dent's Japan disease. Kidney Int. 1998;54:1850–1856
  2. Bolino A, Devoto M, Enia G, Zoccali C, Weissenbach J, Romeo G. Genetic mapping in the Xp11.2 region of a new form of X-linked hypophosphatemic rickets. Eur J Hum Genet. 1993;1:269–279
  3. Frymoyer PA, Scheinman SJ, Dunham PB, Jones DB, Hueber P, Schroeder ET. X-Linked recessive nephrolithiasis with renal failure. N Engl J Med. 1991;325:681–686
  4. Wrong OM, Norden AG, Feest TG. Dent's disease; A familial proximal renal tubular syndrome with low-molecular-weight proteinuria, hypercalciuria, nephrocalcinosis, metabolic bone disease, progressive renal failure and a marked male predominance. QJM. 1994;87:473–493
  5. Cho HY, Lee BH, Choi HJ, Ha IS, Choi Y, Cheong HI. Renal manifestations of Dent disease and Lowe syndrome. Pediatr Nephrol. 2008;23:243–249
  6. Hoopes RR, Shrimpton AE, Knohl SJ, et al. Dent disease with mutations in OCRL1. Am J Hum Genet. 2005;76:260–267
  7. Sekine T, Nozu K, Iyengar R, et al. OCRL1 mutations in patients with Dent disease phenotype in Japan. Pediatr Nephrol. 2007;22:975–980
  8. Utsch B, Bokenkamp A, Benz MR, et al. Novel OCRL1 mutations in patients with the phenotype of Dent disease. Am J Kidney Dis. 2006;48:942 e1–e14
  9. Moulin P, Igarashi T, Van der Smissen P, et al. Altered polarity and expression of H+-ATPase without ultrastructural changes in kidneys of Dent's disease patients. Kidney Int. 2003;63:1285–1295
  10. Piwon N, Gunther W, Schwake M, Bosl MR, Jentsch TJ. ClC-5 Cl–channel disruption impairs endocytosis in a mouse model for Dent's disease. Nature. 2000;408:369–373
  11. Souza-Menezes J, Morales MM, Tukaye DN, Guggino SE, Guggino WB. Absence of ClC5 in knockout mice leads to glycosuria, impaired renal glucose handling and low proximal tubule GLUT2 protein expression. Cell Physiol Biochem. 2007;20:455–464
  12. Ludwig M, Utsch B, Balluch B, Frund S, Kuwertz-Broking E, Bokenkamp A. Hypercalciuria in patients with CLCN5 mutations. Pediatr Nephrol. 2006;21:1241–1250
  13. Cebotaru V, Kaul S, Devuyst O, et al. High citrate diet delays progression of renal insufficiency in the ClC-5 knockout mouse model of Dent's disease. Kidney Int. 2005;68:642–652
  14. Silva IV, Cebotaru V, Wang H, et al. The ClC-5 knockout mouse model of Dent's disease has renal hypercalciuria and increased bone turnover. J Bone Miner Res. 2003;18:615–623
  15. Sayer JA, Carr G, Simmons NL. Nephrocalcinosis: Molecular insights into calcium precipitation within the kidney. Clin Sci (Lond). 2004;106:549–561
  16. Sayer JA, Carr G, Simmons NL. Calcium phosphate and calcium oxalate crystal handling is dependent upon CLC-5 expression in mouse collecting duct cells. Biochim Biophys Acta. 2004;1689:83–90
  17. Scheinman SJ. X-Linked hypercalciuric nephrolithiasis: Clinical syndromes and chloride channel mutations. Kidney Int. 1998;53:3–17
  18. Raja KA, Schurman S, D'Mello RG, et al. Responsiveness of hypercalciuria to thiazide in Dent's disease. J Am Soc Nephrol. 2002;13:2938–2944
  19. Sinaiko AR. Hypertension in children. N Engl J Med. 1996;335:1968–1973
  20. Carlsen JE, Kober L, Torp-Pedersen C, Johansen P. Relation between dose of bendrofluazide, antihypertensive effect, and adverse biochemical effects. BMJ. 1990;300:975–978
  21. Harper R, Ennis CN, Sheridan B, Atkinson AB, Johnston GD, Bell PM. Effects of low dose versus conventional dose thiazide diuretic on insulin action in essential hypertension. BMJ. 1994;309:226–230
  22. Hollander W, Wilkins RW. Chlorothiazide: A new type of drug for the treatment of arterial hypertension. BMQ. 1957;8:69–75
  23. Sorof JM, Cargo P, Graepel J, et al. Beta-blocker/thiazide combination for treatment of hypertensive children: A randomized double-blind, placebo-controlled trial. Pediatr Nephrol. 2002;17:345–350
  24. Norden AG, Scheinman SJ, Deschodt-Lanckman MM, et al. Tubular proteinuria defined by a study of Dent's (CLCN5 mutation) and other tubular diseases. Kidney Int. 2000;57:240–249
  25. Lloyd SE, Pearce SH, Gunther W, et al. Idiopathic low molecular weight proteinuria associated with hypercalciuric nephrocalcinosis in Japanese children is due to mutations of the renal chloride channel (CLCN5). J Clin Invest. 1997;99:967–974
  26. Blanchard A, Jeunemaitre X, Coudol P, et al. Paracellin-1 is critical for magnesium and calcium reabsorption in the human thick ascending limb of Henle. Kidney Int. 2001;59:2206–2215
  27. Bolland MJ, Ames RW, Horne AM, Orr-Walker BJ, Gamble GD, Reid IR. The effect of treatment with a thiazide diuretic for 4 years on bone density in normal postmenopausal women. Osteoporos Int. 2007;18:479–486
  28. Beermann B, Groschinsky-Grind M. Pharmacokinetics of hydrochlorothiazide in man. Eur J Clin Pharmacol. 1977;12:297–303
  29. Berglund G, Andersson O, Larsson O, Wilhelmsen L. Antihypertensive effect and side-effects of bendroflumethiazide and propranolol. Acta Med Scand. 1976;199:499–506
  30. Nijenhuis T, Vallon V, van der Kemp AW, Loffing J, Hoenderop JG, Bindels RJ. Enhanced passive Ca2+ reabsorption and reduced Mg2+ channel abundance explains thiazide-induced hypocalciuria and hypomagnesemia. J Clin Invest. 2005;115:1651–1658
  31. Eladari D, Leviel F, Pezy F, Paillard M, Chambrey R. Rat proximal NHE3 adapts to chronic acid-base disorders but not to chronic changes in dietary NaCl intake. Am J Physiol Renal Physiol. 2002;282:F835–F843
  32. Seikaly MG, Baum M. Thiazide diuretics arrest the progression of nephrocalcinosis in children with X-linked hypophosphatemia. Pediatrics. 2001;108:E6
  33. Cox JP, Yamamoto K, Christie PT, et al. Renal chloride channel, CLCN5, mutations in Dent's disease. J Bone Miner Res. 1999;14:1536–1542
  34. Cheong HI, Lee JW, Zheng SH, et al. Phenotype and genotype of Dent's disease in three Korean boys. Pediatr Nephrol. 2005;20:455–459
  35. Takemura T, Hino S, Ikeda M, et al. Identification of two novel mutations in the CLCN5 gene in Japanese patients with familial idiopathic low molecular weight proteinuria (Japanese Dent's disease). Am J Kidney Dis. 2001;37:138–143

 Trial registration: ClinicalTrials.gov; study number: NCT00638482.

 Originally published online as doi:10.1053/j.ajkd.2008.08.021 on November 3, 2008.

PII: S0272-6386(08)01347-4

doi: 10.1053/j.ajkd.2008.08.021

American Journal of Kidney Diseases
Volume 52, Issue 6 , Pages 1084-1095 , December 2008

Article Tools

* Image Usage & Resolution